pulmonary arterial hypertension (PAH)

The protein LTBP1 is active at high levels in pulmonary arterial hypertension (PAH) and may be a diagnostic marker and therapeutic target in the disease, a new study indicates. “Our study suggests that LTBP1 is involved in the development of PAH and serves as a potential diagnostic and therapeutic…

Liqrev, a new liquid formulation of sildenafil designed for patients who have trouble swallowing tablets, is now available in the U.S., according to an announcement from CMP Pharma, its developer. Liqrev was approved by the U.S. Food and Drug Administration earlier this year as a treatment to improve…

The proportion of people with pulmonary arterial hypertension (PAH) who start on a combination of medications after they’re diagnosed is low, but has increased over the last decade, a study shows. The findings were presented at the 2023 American Thoracic Society (ATS) International Conference, in the poster, “…

Measuring blood levels of three molecules — SAM, guanine, and NT-proBNP — could help identify pulmonary arterial hypertension (PAH) in children with congenital heart diseases (CHD), a study suggests. “This 3-marker panel has the potential to be used in clinical practice for the early diagnosis and screening of PAH-CHD,”…

The identified cause of pulmonary arterial hypertension (PAH) in patients seen at a specialized care center differed substantially from national registry data, a study revealed. Most care center patients were diagnosed with PAH associated with connective tissue disorders and exposure to toxins, whereas idiopathic PAH (IPAH), of unknown cause,…

A joint effort between the startup Owkin and Actelion Pharmaceuticals, one of the Janssen companies, will seek to develop machine learning techniques that could improve how clinical trials are designed, and how the results are analyzed. While the two companies will work to create tools that can be applied…

The cost to treat pulmonary arterial hypertension (PAH) is often exceedingly high, costing more than $200,000 annually. Rare disease markets are much smaller than the typical drug market, meaning the cost of treatments for rare diseases, such as PAH, are priced higher than treatments…

What do you know about pulmonary arterial hypertension? Are you a PAH expert? Maybe you’re simply curious because someone you love has the life-threatening lung condition. Here are some interesting facts you should know about PAH (source: Active Beat): 1. Women are more at risk than men. PAH affects men and women…

What do you know about pulmonary arterial hypertension? Are you a PAH expert? Are you curious because someone you love has the life-threatening lung condition? Here are some interesting facts you should know about PAH (source: Active Beat): PAH affects men and women of all ages and races.

If you’re reading this article, you probably are already very familiar with pulmonary arterial hypertension (PAH). You know that this disease affects the lungs and the heart and that there is currently no cure. Getting a diagnosis of a disease so serious like PAH can be devastating but also…

“Stories that Oxygenate the Soul” is an Argentinian project created to celebrate World Pulmonary Hypertension Day. Read about seven interesting facts about pulmonary hypertension here.  The project documents the lives of five families whose lives are impacted by PH. In this moving video* shared by HIPUA, we get to…

What do you know about pulmonary arterial hypertension? Are you an expert in PAH? Maybe you are simply curious because someone you love has the life-threatening lung condition. Here are some interesting facts you should know about PAH (source: Active Beat website):   PAH affects men and…